Chiron Corporation (CHIR) Announces Licensing Agreement With German Red Cross
10/19/2005 5:08:43 PM
Chiron Corporation (Nasdaq:CHIR) today announced that it has granted a non-exclusive license to the Blood Transfusion Centers of the German Red Cross (Blutspendediensten des Deutsche Rotes Kreuz, or DRK) for use of the company's HIV-1 and hepatitis C virus (HCV) technology for use in molecular probe "home brew" blood screening. Financial terms of the agreement were not disclosed.
comments powered by